Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Coherent-Aktie springt vorbörslich an: Nvidia-Zahlen und Insiderkäufe beflügeln Rebound (Investing.com DE) +++ COHERENT Aktie +4,56%

CARIS LIFE Aktie

 >CARIS LIFE Aktienkurs 
20.6 EUR    +7.9%    (TradegateBSX)
Ask: 20.6 EUR / 253 Stück
Bid: 20 EUR / 260 Stück
Tagesumsatz: 210 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
CARIS LIFE Aktie über LYNX handeln
>CARIS LIFE Performance
1 Woche: -14,0%
1 Monat: -27,4%
3 Monate: +3,7%
6 Monate: +50,8%
1 Jahr: -3,9%
laufendes Jahr: -17,6%
>CARIS LIFE Aktie
Name:  CARIS LIFE SCIENCES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US1421521071 / A41A14
Symbol/ Ticker:  49J (Frankfurt) / CAI (NASDAQ)
Kürzel:  FRA:49J, ETR:49J, 49J:GR, NASDAQ:CAI
Index:  -
Profil:  Caris Life Sciences, Inc. is a precision medicine and diagnostic technology company focused on applying comprehensive molecular information and artificial intelligence to healthcare. Its current services include molecular profiling, genomic and diagn..
>Volltext..
Marktkapitalisierung:  5994.79 Mio. EUR
Unternehmenswert:  5725.34 Mio. EUR
Umsatz:  950.93 Mio. EUR
EBITDA:  147.33 Mio. EUR
Nettogewinn:  87.15 Mio. EUR
Gewinn je Aktie:  0.31 EUR
Schulden:  420.08 Mio. EUR
Liquide Mittel:  603.62 Mio. EUR
Operativer Cashflow:  69.11 Mio. EUR
Bargeldquote:  4.83
Umsatzwachstum:  67.27%
Gewinnwachstum:  -
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  CARIS LIFE
Letzte Datenerhebung:  17.11.26
>CARIS LIFE Kennzahlen
Aktien/ Unternehmen:
Aktien: 286.78 Mio. St.
Frei handelbar: 44.71%
Rückkaufquote: -0.44%
Mitarbeiter: 1846
Umsatz/Mitarb.: 0.4 Mio. EUR
Analysten:
Analystenrating: Buy
Kursziel: 43.57%
Bewertung:
KGV: 71.79
KGV lG: 208.91
KUV: 6.85
KBV: 10.87
PEG-Ratio: -
EV/EBITDA: 38.86
Rentabilität:
Bruttomarge: 69.09%
Gewinnmarge: 9.16%
Operative Marge: 13.35%
Managementeffizenz:
Gesamtkaprendite: 8.58%
Eigenkaprendite: 17.19%
>CARIS LIFE Peer Group
Gesundheit, Kliniken, Pflegeheime & Gesundheitsdienstleistungen, Onkologie/ Krebs- Behandlung
 
17.11.26 - 13:12
Caris Life Sciences: Rebound an 200-Tage-Linie sorgt für vorbörsliche Kursgewinne (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
16.11.26 - 14:33
Caris Life Sciences Presented Research Demonstrating the Value of Whole Transcriptome Sequencing in Precision Oncology at the Association of Molecular Pathology 2026 Annual Meeting (PR Newswire)
 
Two Caris-led studies highlight the power of comprehensive RNA sequencing to identify novel and rare gene fusions across solid tumors IRVING, Texas, Nov. 16, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading next-generation AI TechBio company and precision medicine pioneer,......
11.11.26 - 14:30
Caris Launches Landmark Study to Challenge Fragmented Testing in Myeloid Malignancies (PR Newswire)
 
First patients enrolled in prospective, multi-institutional study evaluating whether a single Whole Genome Sequencing workflow can replace conventional cytogenetics, FISH and targeted NGS testing IRVING, Texas, Nov. 11, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading......
09.11.26 - 14:36
Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer (PR Newswire)
 
Findings suggest ESR1 variant type, number of mutations and estrogen receptor (ER) pathway activity may provide information beyond ESR1 mutation status alone IRVING, Texas, Nov. 9, 2026 /PRNewswire/ -- Caris Life Sciences ® (Caris), a leading TechBio company, today announced the......
05.11.26 - 16:36
Caris Life (CAI) Q3 2026 Earnings Call Transcript (Fool)
 
Clinical volume surged while capacity constraints remain a watch point....
04.11.26 - 22:06
Caris Life Sciences Reports Third Quarter 2026 Financial Results and Increases 2026 Revenue Guidance (PR Newswire)
 
Revenue growth of 27% driven by strong performance in molecular profiling services, including approximately 61,500 clinical cases, consisting of over 358,000 total oncology tests Raises 2026 revenue guidance to $1.04 to $1.05 billion, representing growth of 28% to 29% IRVING, Texas, Nov.......
04.11.26 - 15:48
Caris Life Sciences, Inc. Q3 2026 Earnings Preview (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.10.26 - 13:06
Foundation Medicine Appoints Chadi Nabhan, M.D., MBA, as Chief Medical Officer (Business Wire)
 
BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced the appointment of Chadi Nabhan, M.D., MBA, as chief medical officer, effective November 16, 2026. In this role, Dr. Nabhan will lead the company's global medical affairs and clinical development, accelerating precision oncology for patients at every stage of the disease. Dr. Nabhan brings more than two decades of extensive leadership experience across clinical oncology, academic research, genomics and healthcare technology. Most recently, he served as chief medical officer at Ryght, where he championed the integration of artificial intelligence to optimize clinical trials and research site selection. Prior to that, he was senior vice president and chairman of the Precision Oncology Alliance at Caris Life Sciences, where he expanded the organization's collaborative oncology research network to strengthen precision cancer care for patients. Earlier in his career, he held key positions...
19.10.26 - 12:33
Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection (PR Newswire)
 
New campaign connects AI-powered performance insights linking advanced molecular intelligence to help detect cancer in earlier stages IRVING, Texas, Oct. 19, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the launch of the second......
15.10.26 - 14:33
Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026 (PR Newswire)
 
IRVING, Texas, Oct. 15, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced it will report third quarter 2026 financial results on Wednesday, November 4, 2026. Caris Life Sciences will host a live webcast at 3:30 p.m. CT (4:30 p.m. ET) to......
14.10.26 - 14:39
Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026 (PR Newswire)
 
Eight posters will feature AI-driven approaches to treatment prediction, risk stratification and biomarker discovery advancing precision medicine across multiple cancer types IRVING, Texas, Oct. 14, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today......
29.09.26 - 12:33
Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure (PR Newswire)
 
Integrated DNA, RNA and Whole-Blood Analysis Provides Deeper Molecular Insights for Precision Oncology IRVING, Texas, Sept. 29, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By......
24.09.26 - 05:01
Insiderhandel: Vorstand verkauft Aktien von Caris Life Sciences im Wert von 238626 USD (Insiderkauf)
 
Denton, John Russel - Vorstand - Tag der Transaktion: 2026-09-22...
18.09.26 - 01:01
Insiderhandel: Vorstand verkauft Aktien von Caris Life Sciences im Wert von 12132080 USD (Insiderkauf)
 
Brille, Brian J. - Vorstand - Tag der Transaktion: 2026-09-17...
16.09.26 - 11:30
Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock? (Zacks)
 
Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term....
08.09.26 - 12:33
Caris Life Sciences Launches New National Commercial Featuring Kevin Costner to Raise Awareness of Early Cancer Detection and Caris Detect (PR Newswire)
 
New partnership highlights the importance of finding cancer earlier through Caris Detect, a multi-cancer early detection blood test now available nationwide IRVING, Texas, Sept. 8, 2026 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading TechBio company, today announced the......
05.09.26 - 02:01
Insiderhandel: President verkauft Aktien von Caris Life Sciences im Wert von 2951117 USD (Insiderkauf)
 
Spetzler, David Baxley - Vorstand - Tag der Transaktion: 2026-09-04...
05.09.26 - 02:01
Insiderhandel: President verkauft Aktien von Caris Life Sciences im Wert von 11882989 USD (Insiderkauf)
 
Spetzler, David Baxley - Vorstand - Tag der Transaktion: 2026-09-03...
07.08.26 - 14:33
Caris Precision Oncology Alliance Welcomes the University of New Mexico Comprehensive Cancer Center (PR Newswire)
 
Partnership expands collaborative research network dedicated to advancing precision medicine and improving outcomes for cancer patients IRVING, Texas, Aug. 7, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading TechBio company, today announced that the University of New Mexico......
06.08.26 - 14:33
Caris Life Sciences, ECOG-ACRIN and NRG Oncology Study Demonstrates Multimodal AI Approach to Predict Late Distant Recurrence Risk in HR+ Early Breast Cancer (PR Newswire)
 
Findings published in Cancer Research Communications highlight potential to inform extended endocrine therapy decisions IRVING, Texas, Aug. 6, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading TechBio company, today announced the publication of a study in Cancer Research......
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Die Ehe ist die einzige wahre Form von Leibeigenschaft, die unser Gesetz noch kennt. Es gibt, außer den Herrinnen des Hauses, keine Sklaven mehr. - John Stuart Mill
>Aktienauflistung | >Aktienscreener | >Aktienkennzahlen | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!